401 related articles for article (PubMed ID: 17854227)
21. Quantum-dot-conjugated graphene as a probe for simultaneous cancer-targeted fluorescent imaging, tracking, and monitoring drug delivery.
Chen ML; He YJ; Chen XW; Wang JH
Bioconjug Chem; 2013 Mar; 24(3):387-97. PubMed ID: 23425155
[TBL] [Abstract][Full Text] [Related]
22. 'One-pot' synthesis of multifunctional GSH-CdTe quantum dots for targeted drug delivery.
Chen X; Tang Y; Cai B; Fan H
Nanotechnology; 2014 Jun; 25(23):235101. PubMed ID: 24849381
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
Kim E; Jung Y; Choi H; Yang J; Suh JS; Huh YM; Kim K; Haam S
Biomaterials; 2010 Jun; 31(16):4592-9. PubMed ID: 20206379
[TBL] [Abstract][Full Text] [Related]
24. A graphene quantum dot@Fe
Su X; Chan C; Shi J; Tsang MK; Pan Y; Cheng C; Gerile O; Yang M
Biosens Bioelectron; 2017 Jun; 92():489-495. PubMed ID: 27839733
[TBL] [Abstract][Full Text] [Related]
25. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro.
Liu Z; Duan JH; Song YM; Ma J; Wang FD; Lu X; Yang XD
J Transl Med; 2012 Jul; 10():148. PubMed ID: 22817844
[TBL] [Abstract][Full Text] [Related]
26. Quantum dot-nucleic acid/aptamer bioconjugate-based fluorimetric biosensors.
Zhou D
Biochem Soc Trans; 2012 Aug; 40(4):635-9. PubMed ID: 22817707
[TBL] [Abstract][Full Text] [Related]
27. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.
Yu MK; Kim D; Lee IH; So JS; Jeong YY; Jon S
Small; 2011 Aug; 7(15):2241-9. PubMed ID: 21648076
[TBL] [Abstract][Full Text] [Related]
28. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
[TBL] [Abstract][Full Text] [Related]
29. Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer.
Taghdisi SM; Danesh NM; Sarreshtehdar Emrani A; Tabrizian K; Zandkarimi M; Ramezani M; Abnous K
J Drug Target; 2013 Sep; 21(8):739-44. PubMed ID: 23815443
[TBL] [Abstract][Full Text] [Related]
30. Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro.
Dai B; Hu Y; Duan J; Yang XD
Oncotarget; 2016 Jun; 7(25):38257-38269. PubMed ID: 27203221
[TBL] [Abstract][Full Text] [Related]
31. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
[TBL] [Abstract][Full Text] [Related]
32. Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway.
Sangtani A; Petryayeva E; Wu M; Susumu K; Oh E; Huston AL; Lasarte-Aragones G; Medintz IL; Algar WR; Delehanty JB
Bioconjug Chem; 2018 Jan; 29(1):136-148. PubMed ID: 29191007
[TBL] [Abstract][Full Text] [Related]
33. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
35. Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers.
Min K; Jo H; Song K; Cho M; Chun YS; Jon S; Kim WJ; Ban C
Biomaterials; 2011 Mar; 32(8):2124-32. PubMed ID: 21147500
[TBL] [Abstract][Full Text] [Related]
36. Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance.
Chen X; Cvetkovic D; Ma CM; Chen L
Med Phys; 2012 May; 39(5):2780-6. PubMed ID: 22559650
[TBL] [Abstract][Full Text] [Related]
37. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
[TBL] [Abstract][Full Text] [Related]
38. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
Farokhzad OC; Cheng J; Teply BA; Sherifi I; Jon S; Kantoff PW; Richie JP; Langer R
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6315-20. PubMed ID: 16606824
[TBL] [Abstract][Full Text] [Related]
39. PrP
Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
[TBL] [Abstract][Full Text] [Related]
40. Novel single-stranded DNA binding protein-assisted fluorescence aptamer switch based on FRET for homogeneous detection of antibiotics.
Wang Y; Gan N; Zhou Y; Li T; Cao Y; Chen Y
Biosens Bioelectron; 2017 Jan; 87():508-513. PubMed ID: 27596250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
